When was Inovedis founded?

Inovedis was founded in 2019 and raised its 1st funding round 4 years after it was founded.

Where is Inovedis located?

Inovedis is headquartered in Eden Prairie, United States.

Who is the current CEO of Inovedis?

Lukas Floß and Stefan Welte s of Inovedis. Lukas Floß has also founded 1 company.

How many employees does Inovedis have?

As of Apr 30, 2026, the latest employee count at Inovedis is 9.

Is Inovedis a funded company?

Inovedis is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Oct 04, 2023.

When was the latest funding round of Inovedis?

Inovedis' latest funding was a $***** Series A round on Oct 04, 2023, with participation from 3 investors. Its primary sector is Orthopedics. In United States, the Orthopedics sector has seen $2.48B in funding in 2026 to date.

Where does Inovedis rank among its competitors?

Inovedis ranks 11th amongst 137 active competitors, of which 36 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Meduloc, which secured $4M in Jul, 2026.

Who are the top competitors of Inovedis?

Inovedis' top competitors include RevBio, Miach Orthopaedics and LambdaVision. Among them, Meduloc secured the most recent funding round in July, 2026.

Inovedis - 2026 Company Profile, Team, Funding, Competitors & Financials

Inovedis is a series A company based in Eden Prairie (United States), founded in 2019 by Lukas Floß and Stefan Welte. It operates as a Developer of surgical implants for tendon healing. Inovedis has raised $4M in funding from HTGF. The company has 137 active competitors, including 36 funded and 26 that have exited. Its top competitors include companies like RevBio, Miach Orthopaedics and LambdaVision.

Company Details

Developer of surgical implants for tendon healing. The company's product is the SINEFIX Implant System, to simplify rotator cuff repair procedures and improve patient outcomes.

Key Metrics

Founded Year

2019

Location

Eden Prairie, United States

Stage

Series A

Total Funding

$4M in 1 round

Latest Funding Round

Series A, Oct 04, 2023, $*****

Investors

HTGF & 2 more

Ranked

11^th among 137 active competitors

Employee Count

9 as on Apr 30, 2026

Similar Companies

RevBio & 179 more

View Inovedis' full profile

Inovedis is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
inovedis gmbh CIN: HRB756916 , Germany, Active	May 29, 2016	-	-

Inovedis has raised a total funding of $4M over 1 round. Its latest funding round was a Series A round on Oct 04, 2023 for $*****. 3 investors participated in its latest round. Inovedis has 3 institutional investors.

Here is the list of recent funding rounds of Inovedis:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 04, 2023	1576309	Series A	5876858	3359035	9715481	2052576

Access funding benchmarks and valuations. Sign up today!

View details of Inovedis's funding rounds and investors

The founders of Inovedis are Lukas Floß and Stefan Welte. Stefan Welte and Lukas Floß are the CEOs of Inovedis.

Here are the details of Inovedis' key team members:

Lukas Floß: CEO of Inovedis.
Stefan Welte: Co-Founder & Co-CEO of Inovedis.

View details of Inovedis's Founder profiles and Board Members

Inovedis' employee count trend

Inovedis has 9 employees as of Apr 26. Here is Inovedis's employee count trend over the years:

Uncover Inovedis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Inovedis include RevBio, Miach Orthopaedics and LambdaVision. Here is the list of Top 10 competitors of Inovedis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	RevBio 2014, Lowell (United States), Series B	Developer of synthetic adhesive used for bone/dental repair	$27.5M	Pacific Dental Services, The JHA Capital & 4 others	63/100
2nd	Miach Orthopaedics 2016, Boston (United States), Series B	Developer of surgical implants for connective tissue repair	$79M	Sectoral, Endeavour Vision & 10 others	62/100
3rd	LambdaVision 2009, Farmington (United States), Public	Provider of a protein-based retinal prosthesis for retinal degenerative diseases	$7.65M	Seven Seven Six, Aurelia Foundry & 9 others	57/100
4th	ZuriMED Technologies 2015, Zurich (Switzerland), Acquired	Developer of ligament reconstruction devices	$16.7M	Venture Kick, Chindex Medical & 2 others	56/100
5th	Nanochon 2016, Burke (United States), Seed	Developer of 3D-printed implants for treating joint injuries	$11.3M	cultivate(MD), University of Virginia & 11 others	55/100
6th	Spiderwort 2017, Ottawa (Canada), Series A	Developer of plant-based biomaterials for repair and regeneration of tissues	$16.1M	Horizons Ventures, Flucas Ventures & 10 others	54/100
7th	Tenex Health 2009, Lake (United States), Acquired	Minimally invasive ultrasonic medical devices for chronic tendon pain treatment	$18.5M	VCI Partners, SWK Holdings & 2 others	53/100
8th	Aroa Biosurgery 2008, Mangere (New Zealand), Public	Developer of medical and surgical products for soft tissue reconstruction	-	Alium Capital, Cure Kids Ventures & 2 others	51/100
9th	CGbio 2006, Seongnam-si (South Korea), Unfunded	Solutions for the spectrum of spinal disorders, dentistry, dermal filer and wound management.	-	-	50/100
10th	Meduloc 2016, Del Mar (United States), Series B	Developer of intramedullary implant for internal fixation of small bones fractures	$8M	GenHenn Capital, Ben Franklin Technology Partners ... & 2 others	48/100
11th	Inovedis 2019, Eden Prairie (United States), Series A	Developer of surgical implants for tendon healing	$4M	HTGF, MBG & 1 others	48/100